company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q2,2012-04-01,2012-06-30,2013-09-03 06:31:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7493000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q2,2012-04-01,2012-06-30,2013-09-03 06:31:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7493000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q2,2012-04-01,2012-06-30,2013-09-03 06:31:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7493000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q2,2012-04-01,2012-06-30,2013-09-03 06:31:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1716000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q2,2012-04-01,2012-06-30,2013-09-03 06:31:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9569000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q2,2012-04-01,2012-06-30,2013-09-03 06:31:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11285000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q2,2012-04-01,2012-06-30,2013-09-03 06:31:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3792000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q2,2012-04-01,2012-06-30,2013-09-03 06:31:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q2,2012-04-01,2012-06-30,2013-09-03 06:31:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,34000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q2,2012-04-01,2012-06-30,2013-09-03 06:31:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,33000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q2,2012-04-01,2012-06-30,2013-09-03 06:31:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3759000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q2,2012-04-01,2012-06-30,2013-09-03 06:31:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3759000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q2,2012-04-01,2012-06-30,2013-09-03 06:31:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3759000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q2,2012-04-01,2012-06-30,2013-09-03 06:31:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3759000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q2,2012-04-01,2012-06-30,2013-09-03 06:31:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1000000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q2,2012-04-01,2012-06-30,2013-09-03 06:31:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.64
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q2,2012-04-01,2012-06-30,2013-09-03 06:31:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1000000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q2,2012-04-01,2012-06-30,2013-09-03 06:31:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.64
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q2,2012-04-01,2012-06-30,2013-09-03 06:31:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1032593.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q2,2012-04-01,2012-06-30,2013-09-03 06:31:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.64
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 16:03:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7743000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 16:03:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7743000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 16:03:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7743000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 16:03:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1915000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 16:03:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9496000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 16:03:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11411000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 16:03:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3668000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 16:03:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3668000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 16:03:12+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,13000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 16:03:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3655000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 16:03:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3655000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 16:03:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3655000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 16:03:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1100000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 16:03:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-3.45
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 16:03:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1100000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 16:03:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-3.45
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 16:03:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1060453.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2012.0,Q3,2012-07-01,2012-09-30,2013-11-13 16:03:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-3.45
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2932000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2932000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2932000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1985000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9576000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11561000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8629000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-31000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,31000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8598000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8598000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8598000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8598000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1100000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-7.92
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1100000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-7.92
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1084944.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q1,2013-01-01,2013-03-31,2014-05-08 06:08:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-7.92
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 08:01:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2932000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 08:01:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2932000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 08:01:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2932000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 08:01:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1952000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 08:01:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10475000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 08:01:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12427000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 08:01:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9495000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 08:01:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,149000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 08:01:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-149000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 08:01:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9644000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 08:01:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9644000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 08:01:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9644000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 08:01:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9644000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 08:01:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1100000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 08:01:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-8.83
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 08:01:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1100000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 08:01:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-8.83
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 08:01:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1091782.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q2,2013-04-01,2013-06-30,2014-08-07 08:01:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-8.83
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:16:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12932000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:16:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12932000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:16:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12932000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:16:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3175000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:16:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13126000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:16:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16301000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:16:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3369000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:16:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,117000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:16:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-117000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:16:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3486000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:16:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:16:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3486000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:16:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3486000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:16:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3486000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:16:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23200000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:16:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:16:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23200000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:16:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:16:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23178924.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q3,2013-07-01,2013-09-30,2014-11-04 16:16:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18983000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18983000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18983000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4518000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16871000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21389000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2406000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-7000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2399000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1944000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4343000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4343000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4343000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13500000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,14.97
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13500000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,14.97
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13530239.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,14.97
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6015000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6015000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6015000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3213000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16709000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19922000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13907000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-38000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,38000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13869000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13871000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13871000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13871000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29500000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.47
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29500000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.47
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29443230.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 16:47:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.47
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:28:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6015000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:28:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6015000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:28:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6015000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:28:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3440000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:28:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18167000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:28:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21607000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:28:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15592000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:28:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-6000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:28:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:28:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15586000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:28:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:28:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15597000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:28:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15597000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:28:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15597000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:28:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29400000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:28:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.53
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:28:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29400000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:28:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.53
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:28:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29601010.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:28:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.53
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19015000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19015000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19015000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3515000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21000000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24515000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5500000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-49000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,49000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5451000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,35000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5486000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5486000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5486000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30500000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30500000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29773385.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q3,2014-07-01,2014-09-30,2015-11-05 16:30:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8514000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8514000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8514000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3585000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20554000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24139000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15625000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-12000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,12000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15613000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-557000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15056000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15056000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15056000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29600000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.51
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29600000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29664326.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9687000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9687000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9687000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4794000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19433000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24227000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14540000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-22000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,22000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14518000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14529000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14529000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14529000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29700000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29700000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.49
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29908307.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 16:34:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:45:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4687000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:45:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4687000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:45:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4687000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:45:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4277000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:45:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22045000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:45:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26322000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:45:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21635000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:45:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-27000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:45:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,27000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:45:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21608000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:45:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:45:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21620000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:45:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21620000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:45:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21620000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:45:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30000000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:45:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.72
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:45:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30000000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:45:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.72
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:45:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30022318.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:45:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.72
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:24:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4687000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:24:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4687000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:24:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4687000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:24:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4536000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:24:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24712000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:24:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29248000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:24:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24561000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:24:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-94000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:24:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,94000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:24:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24467000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:24:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:24:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24479000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:24:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24479000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:24:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24479000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:24:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30200000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:24:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.81
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:24:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30200000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:24:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.81
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:24:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30072662.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q3,2015-07-01,2015-09-30,2016-11-01 16:24:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.81
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6155000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,683000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6838000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6838000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4976000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26683000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31659000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24821000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-27000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,27000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24794000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-15000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24779000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24779000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24779000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30100000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.82
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30100000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.82
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30028684.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.82
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5348000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1002000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6350000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6350000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5199000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28398000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,33597000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27247000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-37000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,37000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27210000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27213000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27213000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27213000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30200000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.9
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30200000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.9
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30221634.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 16:44:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.9
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5348000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:42+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1317000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6665000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6665000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4773000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,29708000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34481000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27816000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-129000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,129000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27687000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27691000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27691000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27691000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30400000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.91
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30400000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.91
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30300754.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 16:16:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.91
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:29:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5279000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:29:27+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,640000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:29:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5919000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:29:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5919000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:29:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4493000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:29:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27361000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:29:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31854000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:29:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25935000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:29:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-80000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:29:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,80000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:29:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25855000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:29:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:29:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25864000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:29:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25864000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:29:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-25864000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:29:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33600000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:29:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.77
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:29:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33600000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:29:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.77
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:29:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33758423.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q3,2016-07-01,2016-09-30,2017-11-02 16:29:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.77
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9178000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-2959000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6219000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6219000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4362000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,24246000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28608000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22389000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,246000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,299000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,53000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22336000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22334000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22334000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22334000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32800000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.56
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32800000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.56
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32859554.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.56
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5302000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,911000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6213000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6213000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4984000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23987000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28971000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22758000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-154000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,154000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22604000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22608000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22608000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22608000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37100000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.61
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37100000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.61
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37271023.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 16:16:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.61
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 08:46:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6195000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 08:46:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6195000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 08:46:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6195000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 08:46:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4097000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 08:46:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15090000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 08:46:34+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2443000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 08:46:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21630000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 08:46:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15435000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 08:46:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-214000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 08:46:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,214000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 08:46:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15221000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 08:46:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 08:46:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15225000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 08:46:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15225000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 08:46:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15225000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 08:46:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38100000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 08:46:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 08:46:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38100000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 08:46:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 08:46:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37623751.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q2,2017-04-01,2017-06-30,2018-08-02 08:46:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:21:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5106000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:21:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5106000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:21:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5106000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:21:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3871000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:21:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12191000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:21:55+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,69000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:21:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16131000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:21:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11025000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:21:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,337000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:21:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,337000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:21:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10688000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:21:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:21:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10692000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:21:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10692000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:21:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10692000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:21:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37662868.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:21:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:21:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37662868.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:21:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:21:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38200000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q3,2017-07-01,2017-09-30,2018-11-01 16:21:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21551000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-911000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20640000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,20640000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3809000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8571000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,15000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12395000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8245000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,368000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,491000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,123000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8368000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1095000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9463000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9463000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9463000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37600000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.25
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37600000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.25
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37631348.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.25
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7849000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7849000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7849000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5394000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8387000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13781000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5932000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-363000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,363000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5569000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5574000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5574000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5574000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37200000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37200000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38243427.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q1,2018-01-01,2018-03-31,2018-05-08 16:16:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 08:46:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6870000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 08:46:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6870000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 08:46:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6870000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 08:46:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3704000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 08:46:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8054000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 08:46:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11758000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 08:46:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4888000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 08:46:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-524000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 08:46:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,524000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 08:46:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4364000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 08:46:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-388000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 08:46:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3976000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 08:46:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3976000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 08:46:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3976000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 08:46:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,39800000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 08:46:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 08:46:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,39800000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 08:46:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 08:46:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38389626.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q2,2018-04-01,2018-06-30,2018-08-02 08:46:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,2018-11-01 16:21:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19518000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,2018-11-01 16:21:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19518000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,2018-11-01 16:21:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19518000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,2018-11-01 16:21:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3702000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,2018-11-01 16:21:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10025000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,2018-11-01 16:21:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13727000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,2018-11-01 16:21:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5791000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,2018-11-01 16:21:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,324000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,2018-11-01 16:21:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,324000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,2018-11-01 16:21:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6115000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,2018-11-01 16:21:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6115000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,2018-11-01 16:21:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6115000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,2018-11-01 16:21:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6115000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,2018-11-01 16:21:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38508204.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,2018-11-01 16:21:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,2018-11-01 16:21:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38512526.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,2018-11-01 16:21:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.16
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,2018-11-01 16:21:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38200000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q3,2018-07-01,2018-09-30,2018-11-01 16:21:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10184000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10184000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10184000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5372000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7977000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1851000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15200000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5016000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,887000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1238000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,351000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4665000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4666000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4666000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4666000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38600000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38600000.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38442994.0
OncoMed Pharmaceuticals Inc,OMED,,0001302573,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
